SGCB and schizophrenia: In line with this, these gene sets including the NO-sGC, reduction of cytosolic Ca and cGMP effects gene sets were also associated with mental health as previously reported in schizophrenia treatment [88], anti-depressive effects [86], pharmacological intervention for enhancing learning and memory formation and performance [85,89,90,91] and neuroprotective effects [92].